4.6 Article

An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B

Journal

JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 11, Issue 7, Pages 1329-1340

Publisher

WILEY
DOI: 10.1111/jth.12276

Keywords

bioinformatics; coagulation factor IX; database; hemophilia B; models; molecular; mutations; phenotypes

Funding

  1. Pfizer UK
  2. Special Trustees of the Royal Free Hospital
  3. Katharine Dormandy Trust for Haemophilia and Related Disorders

Ask authors/readers for more resources

Background Factor IX (FIX) is important in the coagulation cascade, being activated to FIXa on cleavage. Defects in the human F9 gene frequently lead to hemophilia B. Objective To assess 1113 unique F9 mutations corresponding to 3721 patient entries in a new and up-to-date interactive web database alongside the FIXa protein structure. Methods The mutations database was built using MySQL and structural analyses were based on a homology model for the human FIXa structure based on closely-related crystal structures. Results Mutations have been found in 336 (73%) out of 461 residues in FIX. There were 812 unique point mutations, 182 deletions, 54 polymorphisms, 39 insertions and 26 others that together comprise a total of 1113 unique variants. The 64 unique mild severity mutations in the mature protein with known circulating protein phenotypes include 15 (23%) quantitative type I mutations and 41 (64%) predominantly qualitative type II mutations. Inhibitors were described in 59 reports (1.6%) corresponding to 25 unique mutations. Conclusion The interactive database provides insights into mechanisms of hemophilia B. Type II mutations are deduced to disrupt predominantly those structural regions involved with functional interactions. The interactive features of the database will assist in making judgments about patient management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Diagnosis of rare bleeding disorders

Karina Meijer, Waander van Heerde, Keith Gomez

Summary: Rare bleeding disorders have significant morbidity but are often underdiagnosed globally. Advances in genomic testing and specialist laboratory assays have greatly improved the diagnostic capabilities, leading to the discovery of new genetic causes for rare diseases and a better understanding of their underlying molecular pathology.

HAEMOPHILIA (2021)

Review Obstetrics & Gynecology

The presentation and outcomes of Hermansky-Pudlak syndrome in obstetrics and gynecological settings: A systematic review

Deborah Obeng-Tuudah, Brwa A. Hussein, Amir Hakim, Keith Gomez, Rezan Abdul Kadir

Summary: Hermansky-Pudlak syndrome (HPS) is a rare autosomal-recessive disorder characterized by bleeding diathesis and oculocutaneous albinism in women. Management strategies for women with HPS include desmopressin and platelet transfusions, with close collaboration between obstetrics and gynecology and hematology teams recommended. Heavy menstrual bleeding and post-partum hemorrhage may lead to diagnosis of HPS in affected women.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)

Article Hematology

GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis

Karyn Megy, Kate Downes, Marie-Christine Morel-Kopp, Jose M. Bastida, Shannon Brooks, Loredana Bury, Eva Leinoe, Keith Gomez, Neil V. Morgan, Maha Othman, Willem H. Ouwehand, Juliana Perez Botero, Jose Rivera, Harald Schulze, David-Alexandre Tregouet, Kathleen Freson

Summary: The implementation of high-throughput sequencing technologies has identified many new genes related to rare bleeding, thrombotic, and platelet disorders, but the lack of well-curated databases and submission processes hampers further research progress in understanding these disorders.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Medicine, General & Internal

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Lise J. Estcourt, Alexis F. Turgeon, Zoe K. McQuilten, Bryan J. McVerry, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Donald M. Arnold, Abigail Beane, Philippe Begin, Wilma van Bentum-Puijk, Lindsay R. Berry, Zahra Bhimani, Janet E. Birchall, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Meredith Buxton, Jeannie L. Callum, Michael Chasse, Allen C. Cheng, Matthew E. Cove, James Daly, Lennie Derde, Michelle A. Detry, Menno De Jong, Amy Evans, Dean A. Fergusson, Matthew Fish, Mark Fitzgerald, Claire Foley, Herman Goossens, Anthony C. Gordon, Iain B. Gosbell, Cameron Green, Rashan Haniffa, Heli Harvala, Alisa M. Higgins, Thomas E. Hills, Veronica C. Hoad, Christopher Horvat, David T. Huang, Cara L. Hudson, Nao Ichihara, Emma Laing, Abigail A. Lamikanra, Francois Lamontagne, Patrick R. Lawler, Kelsey Linstrum, Edward Litton, Elizabeth Lorenzi, Sheila MacLennan, John Marshall, Daniel F. McAuley, John F. McDyer, Anna McGlothlin, Shay McGuinness, Gail Miflin, Stephanie Montgomery, Paul R. Mouncey, Srinivas Murthy, Alistair Nichol, Rachael Parke, Jane C. Parker, Nicole Priddee, Damian F. J. Purcell, Luis F. Reyes, Peter Richardson, Nancy Robitaille, Kathryn M. Rowan, Jennifer Rynne, Hiroki Saito, Marlene Santos, Christina T. Saunders, Ary Serpa Neto, Christopher W. Seymour, Jon A. Silversides, Alan A. Tinmouth, Darrell J. Triulzi, Anne M. Turner, Frank van de Veerdonk, Timothy S. Walsh, Erica M. Wood, Scott Berry, Roger J. Lewis, David K. Menon, Colin McArthur, Ryan Zarychanski, Derek C. Angus, Steve A. Webb, David J. Roberts, Manu Shankar-Hari

Summary: Among critically ill adults with confirmed COVID-19, treatment with 2 units of high-titer, ABO-compatible convalescent plasma had a low likelihood of providing improvement in the number of organ support-free days.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Hematology

Advances in the diagnosis of heritable platelet disorders

Keith Gomez

Summary: In the last decade, the number of patients with heritable platelet disorders in national databases of bleeding disorders has significantly increased. This revolution has been made possible through the use of high-throughput sequencing strategies and efforts to standardize diagnostic testing. New microscopy techniques could improve the diagnostic yield of peripheral blood smears and assist in determining the need for specialist testing.

BLOOD REVIEWS (2022)

Article Hematology

Diagnosis of rare bleeding disorders

Karina Meijer, Waander van Heerde, Keith Gomez

Summary: Advancements in genomic testing and specialist laboratory assays have greatly improved the diagnostic accuracy of rare bleeding disorders, leading to the discovery of new genetic causes and a better understanding of the underlying molecular pathology.

HAEMOPHILIA (2022)

Article Medicine, General & Internal

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Charlotte A. Bradbury, Patrick R. Lawler, Simon J. Stanworth, Bryan J. McVerry, Zoe McQuilten, Alisa M. Higgins, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Lindsay R. Berry, Elizabeth Lorenzi, Ryan Zarychanski, Yaseen M. Arabi, Djillali Annane, Abi Beane, Wilma Van Bentum-Puijk, Zahra Bhimani, Shailesh Bihari, Marc J. M. Bonten, Frank M. Brunkhorst, Adrian Buzgau, Meredith Buxton, Marc Carrier, Allen C. Cheng, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Mark Fitzgerald, Timothy D. Girard, Ewan C. Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, David T. Huang, Christopher M. Horvat, Beverley J. Hunt, Nao Ichihara, Francois Lamontagne, Helen L. Leavis, Kelsey M. Linstrum, Edward Litton, John C. Marshall, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Saskia Middeldorp, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Luis Reyes, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Ary Serpa-Neto, Christopher W. Seymour, Manu Shankar-Hari, Vanessa Singh, Timo Tolppa, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Lennie P. G. Derde, Steve A. Webb, Anthony C. Gordon

Summary: The study results showed that among critically ill patients with COVID-19, treatment with an antiplatelet agent compared with no antiplatelet agent did not significantly improve the number of organ support-free days within 21 days. The use of antiplatelet therapy in critically ill patients with COVID-19 did not show significant benefits.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Review Hematology

Reproductive health and hemostatic issues in women and girls with congenital factor VII deficiency: A systematic review

Rezan Abdul-Kadir, Keith Gomez

Summary: This systematic review investigated the prevalence and management of bleeding symptoms associated with gynecological and obstetric issues in women with Congenital factor VII (FVII) deficiency. The results showed that women with FVII deficiency often experience heavy menstrual bleeding, ovarian bleeding, and postpartum hemorrhage, which can impact their quality of life. However, the management of these bleeding complications is inconsistent due to the lack of treatment guidelines.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Medicine, General & Internal

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial

Pratima Chowdary, Banwari Agarwal, Maria Rita Peralta, Sanjay Bhagani, Simon Lee, James Goldring, Marc Lipman, Emal Waqif, Mark Phillips, Helen Philippou, Jonathan H. Foley, Nicola J. Mutch, Robert A. S. Ariens, Kathleen A. Stringer, Federico Ricciardi, Marie Watissee, Derralynn Hughes, Amit Nathwani, Anne Riddell, David Patch, Jim Buckley, Mark De Neef, Rahul Dimber, Cecilia Diaz-Garcia, Honey Patel, Aarti Nandani, Upuli Dissanayake, Nick Chadwick, Ahmed A. A. M. M. Alkhatip, Peter Watkinson, Eamon Raith, Suveer Singh, Tony Wolff, Rajeev Jha, Simon E. Brill, Ameet Bakhai, Alison Evans, Farhat Gilani, Keith Gomez

Summary: Nebulized recombinant tissue plasminogen activator (rt-PA) has the potential to improve lung injury and oxygenation in COVID-19 patients. Preliminary studies show better outcomes in patients receiving non-invasive respiratory support (NIRS). Randomized clinical trials are needed to confirm the clinical effects.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Hematology

Postmortem diagnosis of severe factor X deficiency in a fetus with intracranial hemorrhage resulting in intrauterine death

Evelien Krumb, Nishita Mehta, Ciaran Hutchinson, Bilal Jradeh, Ewa Jaslowska, Keith Gomez, Rezan Abdul-Kadir

Summary: This article describes a case of fetal death at 26 weeks due to massive intracranial hemorrhage (ICH) in patients with severe congenital factor X deficiency. Gene panel analysis of postmortem samples revealed a pathologic F10 gene variant that causes a significant reduction in FX levels. The parents were heterozygous for this variant and had no personal or family history of abnormal bleeding. This is the first reported case of severe FX deficiency resulting in ICH diagnosed through postmortem genetic analysis, highlighting the importance of exploring the etiology of fetal or neonatal ICH and treating potential coagulopathy in children.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Meeting Abstract Hematology

Time-in- therapeutic range (TTR) falls as the target INR range increases in patients on warfarin

Imran Malik, Paul Priest, Ian Jennings, Keith Gomez

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Obstetrics & Gynecology

Platelet storage pool disorder in pregnancy: Utilising thromboelastography to guide a risk-based delivery plan

Timothy A. C. Snow, Rezan A. Abdul-Kadir, Keith Gomez, Adrian England

Summary: This case study presents a 33-year-old woman in her third pregnancy with platelet storage pool disorder, who successfully minimised her risk of major obstetric haemorrhages through a peripartum plan devised by an extensive multi-disciplinary team. The use of point-of-care thromboelastography was also highlighted as a valuable tool in guiding management decisions and facilitating individualised risk-benefit discussions for anaesthetic choices.

OBSTETRIC MEDICINE (2022)

Correction Hematology

guidelines on the investigation and management of venous thrombosis at unusual sites (vol 159, pg 28, 2012)

Renu Riat, Keith Gomez

BRITISH JOURNAL OF HAEMATOLOGY (2022)

No Data Available